The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending the approval of Copiktra as monotherapy for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukaemia after at least two prior therapies and follicular lymphoma that is refractory to at least two prior systemic therapies.
The National Cancer Institute approved the following clinical research studies last month.
A retrospective study conducted by a team of NCI researchers is dispelling the widely held notion that small cell lung cancer is almost exclusively tied to a history of smoking.
José Baselga, an expert in the development of molecular targeted agents and an executive at AstraZeneca, died of Creutzfeldt-Jakob, an extremely rare, rapidly progressing, degenerative brain disorder.
The NCI Board of Scientific Advisors approved 12 new and reissue concepts.
Amy Abernethy is leaving her positions as FDA principal deputy commissioner and acting chief information officer in mid- to late April, the agency said.
John C. Byrd, the D. Warren Brown Chair of Leukemia Research at the Ohio State University College of Medicine, was named professor and chair of the University of Cincinnati College of Medicine Department of Internal Medicine.
Washington University School of Medicine in St. Louis and Barnes-Jewish Hospital have established the Brain Tumor Center, to provide care for brain tumor patients while also developing transformative basic, translational and clinical research to develop new therapies and improve patient outcomes.
Marcelo Bonini and Devalingam Mahalingam were named to new leadership positions at Lurie Cancer Center.
Gyorgy Paragh was named the Lawrence P. & Joan Castellani Family Chair in Dermatology and head of the Department of Dermatology at Roswell Park Comprehensive Cancer Center.
